This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sat May 18, 2013 5:00 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
 Post subject: Neuren - NZ company
PostPosted: Fri Jul 08, 2005 8:28 am 
Offline
Family Elder
User avatar

Joined: Fri Sep 10, 2004 3:00 pm
Posts: 1889
Dear all,

In March it was reported that the US Army were taking up a brain injury drug which was in early trials. The company behind the drug are Neuren. A link to their website is attached.

http://www.neurenpharma.com/

The company are developing some interesting products relevant to MS (see under Technology and Development Pipeline). Many of the drugs are neuro-protective, but they also have a peptide in development to repair / regenerate neurons. Perhaps an effectiveness test in the future will be how much our brain volume has increased.

Bromley


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Update on Neuren

bromley

0

1207

Sat Jul 16, 2005 5:33 am

bromley View the latest post

There are no new unread posts for this topic. Interesting startup company

dignan

0

1175

Fri Jun 16, 2006 8:35 am

dignan View the latest post

There are no new unread posts for this topic. New drug, new company (1st phase trial)

RuSmolikova

3

1421

Tue Jan 11, 2011 7:16 am

Algis View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: